Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kellokumpu-Lehtinen, Pirkko-Liisa i
NCT00653848 / 2006-001657-94: Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy	Active, not recruiting	3	378	Europe	docetaxel, LHRH ananlog 9 months	Scandinavian Prostate Cancer Group, Sanofi	Prostate Cancer	08/23	08/23